The American Journal of Managed Care

Late Presentation of HIV Most Common in Older Patients

Older patients and patients of sub-Saharan African origin were at an increased risk of late presentation of advanced HIV. Late presentation of advanced HIV is most common in patients of older age and ...
Morningstar

GSK: HIV Presentation Highlights Long-Duration Dosing Options to Help Mitigate 2028 Patent Losses

GSK hosted an analyst presentation on its HIV segment (close to 20% of total sales) signaling increased focus on developing longer-duration therapies. While the updates don’t have an impact on our ...
Labroots

Panel Presentation: Update on Emerging HIV Drug Resistance to Integrase Inhibitors - How Concerned Should We Be? With Live Q&A

Effective control of the spread of HIV depends on using the right antiretroviral drugs. In 2019, the World Health Organization recommended using the integrase inhibitor, dolutegravir (DTG), in first- ...
Medscape

Late HIV Tied to Misclassifications in European Surveillance Efforts

European public health authorities have met a formidable opponent in the race to end the AIDS epidemic by 2030: late HIV. However, it appears that many cases were captured during seroconversion (when ...
News Medical

Exploring Mpox severity among advanced HIV patients

In a recent study published in The Lancet, researchers assessed the incidence of mpox in individuals with advanced human immunodeficiency virus (HIV) infection. In July 2022, the World Health ...